Atlas Trials

Fulvestrant Plus Enzalutamide in ER+/Her2- Advanced Breast Cancer

Clinical trial NCT02953860 · COMPLETED

Trial details

NCT number
NCT02953860
Sponsor
University of Colorado, Denver
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Breast Cancer
Start date
2017-07-06
Primary completion
2019-11-21
Enrollment
32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.